மருந்து வளர்ச்சி உச்சிமாநாடு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருந்து வளர்ச்சி உச்சிமாநாடு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருந்து வளர்ச்சி உச்சிமாநாடு Today - Breaking & Trending Today

Poxel SA: Poxel Reports Financial Results for First Half 2021 and Provides a Corporate Update

Poxel SA: Poxel Reports Financial Results for First Half 2021 and Provides a Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France General , United States , South Korea , Arthur Rouill , John Kozarich , Thomas Kuhn , Sumitomo Dainippon Pharma , Valeria Fisher , Catherine David , Sophie Bozec , Drug Development Summit , Meeting Of The Japan Diabetes Society , Trophic Communications , Scientific Committee Of The Board , Phepatology Communications , Clinical Development Updates , National Organization For Rare Diseases , Financial Press , Public Relations Corporate Communications , World Congress , International Liver Congress , Sumitomo Dainippon , Extraordinary General Meeting , Scientific Committee , Extraordinary General , Annual Meeting ,

Poxel SA: Poxel Announces its Participation at the Mitochondria-Targeted Drug Development Summit

Poxel SA: Poxel Announces its Participation at the Mitochondria-Targeted Drug Development Summit
POXEL SA (Euronext POXEL FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH) today announced its participation at the Mitochondria-Targeted Drug Development Summit (April 27-29).
On April 29, Sophie Bozec, PhD, Senior Vice President, R&D Pharmacology and Scientific Communication, and Co-Founder of Poxel is presenting a talk entitled Mitochondrial Dysfunction in Metabolic Diseases
during the session -
Clinical Stage Molecules Targeting Mitochondrial Mechanisms. The presentation highlights Poxel s scientific focus and deep expertise in mechanisms which modulate cellular energy homeostasis and address mitochondrial dysfunction. ....

United States , South Korea , Sumitomo Dainippon Pharma , Arthur Rouill , Valeria Fisher , Catherine David , Sophie Bozec , Drug Development Summit , World Health Organization , Devices Agency , Trophic Communications , Mitochondria Targeted Drug Development Summit , Senior Vice President , Scientific Communication , Clinical Stage Molecules Targeting Mitochondrial , Southeast Asian , Medical Devices Agency , Euronext Paris , Relations Communication Manager , Media France , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கொரியா , வலேரியா மீனவர் , கேத்தரின் டேவிட் , மருந்து வளர்ச்சி உச்சிமாநாடு , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் ,

Poxel Announces its Participation at the Mitochondria-Targeted Drug Development Summit

Share:
POXEL SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH) today announced its participation at the Mitochondria-Targeted Drug Development Summit (April 27-29).
On April 29, Sophie Bozec, PhD, Senior Vice President, R&D Pharmacology and Scientific Communication, and Co-Founder of Poxel is presenting a talk entitled Mitochondrial Dysfunction in Metabolic Diseases
during the session -
Clinical Stage Molecules Targeting Mitochondrial Mechanisms. The presentation highlights Poxel s scientific focus and deep expertise in mechanisms which modulate cellular energy homeostasis and address mitochondrial dysfunction.
Results pertaining to the mode of action for Imeglimin, PXL770 and PXL065 will be discussed. In addition, the presentation will feature novel data related to the utility of Poxel s AMP-kinase ....

United States , South Korea , Sumitomo Dainippon Pharma , Sophie Bozec , Drug Development Summit , World Health Organization , Devices Agency , Mitochondria Targeted Drug Development Summit , Senior Vice President , Scientific Communication , Clinical Stage Molecules Targeting Mitochondrial , Southeast Asian , Medical Devices Agency , Euronext Paris , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கொரியா , மருந்து வளர்ச்சி உச்சிமாநாடு , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , மூத்தவர் துணை ப்ரெஸிடெஂட் , அறிவியல் தொடர்பு , தென்கிழக்கு ஆசிய ,

Poxel SA: Poxel Provides Corporate Update and Reports Cash and Revenue for the First Quarter 2021

Poxel SA: Poxel Provides Corporate Update and Reports Cash and Revenue for the First Quarter 2021
with product launch anticipated in 2021
1
Poxel regained Imeglimin rights from Metavant for US, Europe and other countries not covered by its agreement with Sumitomo Dainippon Pharma and is pursuing next steps to advance its development including partnering activities
Poxel continues to prepare for initiation of Phase 2b trial with PXL770 in patients with biopsy-proven NASH and pre-diabetes or type 2 diabetes, expected to commence in H2 2021
PXL065 Phase 2 study ongoing with completion of recruitment expected in mid-2021 and topline data readout in mid-2022
Imeglimin and PXL065 preclinical and clinical data published in peer reviewed journals; PXL770 data accepted for oral and poster presentations at an upcoming scientific conference ....

United States , South Korea , Arthur Rouill , Merck Serono , Thomas Kuhn , Sumitomo Dainippon Pharma , Valeria Fisher , Catherine David , Additional Development Opportunities , Raymond James Human Health Innovations Conference , Drug Development Summit , World Health Organization , Meeting Of The Japanese Diabetes Society , Trophic Communications , Phepatology Communications , Clinical Development Updates , Kempen Life Sciences Conference , Devices Agency , Financial Press , Imeglimin Japanese New Drug Application , Medical Devices Agency , Fiscal Year , Sumitomo Dainippon , European Association , Pioglitazone Efficacy , Exhibits Little ,

Poxel Provides Corporate Update and Reports Cash and Revenue for the First Quarter 2021

Poxel Provides Corporate Update and Reports Cash and Revenue for the First Quarter 2021
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

United States , South Korea , Arthur Rouill , Merck Serono , Thomas Kuhn , Sumitomo Dainippon Pharma , Valeria Fisher , Catherine David , Additional Development Opportunities , Raymond James Human Health Innovations Conference , Drug Development Summit , World Health Organization , Meeting Of The Japanese Diabetes Society , Trophic Communications , Phepatology Communications , Clinical Development Updates , Kempen Life Sciences Conference , Devices Agency , Financial Press , Poxel Provides Corporate Update , Reports Cash , First Quarter , Japanese New Drug Application , Medical Devices Agency , Fiscal Year , Sumitomo Dainippon ,